A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

计划入组 12 人 · 首次发布于 2025 年 12 月 1 日

Behavioral Effects of Drugs (Inpatient): 38

计划入组 5 人 · 首次发布于 2019 年 5 月 17 日

38 Week Extension Study to CAIN457C2303

计划入组 59 人 · 首次发布于 2010 年 3 月 26 日

MS-38

L-38

CCI-38

Advanced Accelerator Applications SA

France

Alvotech hf

Iceland

Phio Pharmaceuticals

United States

CuraCell Receives German Approval for Phase I/IIa Trial of CC-38 TIL Therapy in Metastatic Cancers

Cocrystal Pharma's CC-42344 Shows Activity Against H5N1 Avian Influenza in Preclinical Studies

Cocrystal Pharma's CC-42344 Shows 1,000-Fold Greater Potency Than Tamiflu Against H5N1 Avian Influenza